Peter Leedman is the Director of the Harry Perkins Institute of Medical Research (‘Perkins’), Head of the Perkins Laboratory for Cancer Medicine and Professor of Medicine (endocrinologist) at Royal Perth Hospital. He graduated in Medicine from The University of Western Australia, completed his PhD at the Walter and Eliza Hall Institute of Medical Research and undertook post-doctoral studies at Harvard Medical School. He is internationally recognised for his research on the molecular mechanisms of hormone action, especially in poor prognostic tumours, such as head, neck and liver cancer. He co-founded miReven, a spin out company established to commercialise a replacement therapy for cancer, and is driving this initiative towards an early phase clinical trial in patients with liver cancer. He is also Chairman of Linear Clinical Research Ltd, a world-class company specializing in early phase clinical trials, with a focus on cancer, which is a wholly owned subsidiary of the Harry Perkins Institute.
During a turbulent year, supporters for the Harry Perkins Institute of Medical Research have continued to rally behind the major events that underpin vital cancer research in WA.
Science steps up in a time of crisis.
Never in our lifetime have so many Australians, and so many across the globe, been so affected by a single health issue.
AUSTRALIA’S master of interpreting census and other data, Bernard Salt, last year wrote that, in relative terms, Indigenous business is booming, growing at an average rate of around 600 new busines
WHEN the U.S Department of Defence wanted a trial of a new drug that could possibly benefit their soldiers in the field, they did a global search for somewhere that offered quality drug trials and
A common garden plant with purple, tubular bell-like flowers is a vital natural resource, that often goes unrecognised, but is responsible for extending the lives of many West Australians.
World class specialists, first class hospitals, skilled health workers, a dynamic clinical trials culture and internationally regarded scientists researching and analysing diseases.
Fortunately in our country we can be fairly confident that considerations about our energy future factor in direct environmental impacts but should we be going further and considering a wider clima
As editor of Business News, I’m delighted to introduce a new feature that highlights the best of Western Australia. Great for the State is a 12-page lift-out that will be published each month over the course of 2019.
At the Harry Perkins Institute of Medical Research in Nedlands, Dr Anabel Sorolla Bardaji and a cancer research team, is investigating the use of tiny ‘nanoparticles’ as a treatment fo
The search for disease genes that affect people’s ability to perform voluntary movements is taking Perth scientist Sarah Beecroft, and precious genetic material from Australia and New Zealand, to L
We know cancer is the uncontrolled division of abnormal cells in a part of the body and that it can occur in almost any type of tissue cell, which means the term cancer actually refers to o
When any of us needs a little inspiration at the Perkins there’s a small sample of mould we can visit that’s mounted on the wall in a little plastic container on the first floor.
The Harry Perkins Institute of Medical Research (Perkins) in Perth has been awarded three of Australia’s most prestigious Research Fellowships from the National Health and Medical Research Council
Recently, five much loved WA artists took on a novel challenge of expressing their support for medical research by decorating lab coats in their distinctive styles.
The Federal Government last month announced the largest single investment of the Medical Research Future Fund.It focuses on screening for genetic diseases.
If you’re suffering from advanced stages of cancer the best news your oncologist can deliver, apart from saying you’re winning the battle, is that you’re eligible for a promising new drug trial.
Researchers from the Harry Perkins Institute of Medical Research have helped explain the high failure rate of one of the most commonly used medical devices in the world.
Researchers at the Harry Perkins Institute of Medical Research have identified a group of genes that are a likely cause of atrial fibrillation, or the rapid beating of the heart.